HL7 Australia Implementation Guide:

This page is part of the RCPA Cancer Protocols IG (v0.1.0: Release 1 Draft) based on FHIR R3. . For a full list of available versions, see the Directory of published versions

Generated Example

{
  "resourceType" : "Prostate",
  "id" : "Prostate-genexample-5",
  "subject" : {
    "reference" : "Patient/8003608666698535"
  },
  "requester" : {
    "reference" : "Practitioner/8003616566682137"
  },
  "performer" : {
    "reference" : "Organization/8003623233350148"
  },
  "preAnalytic" : {
    "clinicalHistory" : [
      "Core biopsy Gleason score: 4+5=9"
    ],
    "psa" : [
      {
        "value" : 10,
        "unit" : "ng/mL",
        "system" : "http://unitsofmeasure.org",
        "code" : "ng/mL"
      }
    ]
  },
  "macro" : {
    "specimenWeight" : {
      "value" : 35,
      "unit" : "g",
      "system" : "http://unitsofmeasure.org",
      "code" : "g"
    },
    "specimenDimension1" : {
      "value" : 45,
      "unit" : "mm",
      "system" : "http://unitsofmeasure.org",
      "code" : "mm"
    },
    "specimenDimension2" : {
      "value" : 35,
      "unit" : "mm",
      "system" : "http://unitsofmeasure.org",
      "code" : "mm"
    },
    "specimenDimension3" : {
      "value" : 27,
      "unit" : "mm",
      "system" : "http://unitsofmeasure.org",
      "code" : "mm"
    },
    "otherMacroComments" : "Volume: 3.3cm3 (3D volume estimate method)."
  },
  "micro" : {
    "tumourType" : [
      "45410002"
    ],
    "tumourFocality" : [
      "Multifocal"
    ],
    "histologicalGrade" : {
      "primary" : "369773008",
      "secondary" : {
        "value" : 369774002
      },
      "tertiary" : {
        "value" : 369772003
      },
      "score" : "Composite Gleason Score (ISUP) 2005): 4+5=9
Index carcinoma score (ISUP 2005): 4+5=9
% High Grade (4/5): 90%.
Intraduct carcinoma: Absent."
    },
    "extraprostaticExtension" : {
      "code" : "372306004",
      "extent" : "420366008",
      "location" : [
        "Posterolateral"
      ],
      "comment" : "Measurement (radial): 0.4mm"
    },
    "margin" : {
      "status" : "55182004",
      "locationDescription" : "Tumour location:  
Quadrants: All four
Zones:Peripheral, base and apex"
    },
    "seminalVesicles" : "not_involved",
    "lymphNodeStatus" : {
      "number" : {
        "value" : 5
      },
      "numberPositive" : {
        "value" : 0
      },
      "sitesInvolved" : "Not involved",
      "invasion" : "not_identified"
    }
  },
  "synthesisOverview" : {
    "tumourStageT" : "384987006",
    "diagnosticSummary" : "1. Radical prostatectomy: Adenocarcinoma
2. Right pelvic lymph nodes: No evidence of malignancu (0/4)
3. Periprostatic fat: No evidence of malignancy",
    "overarchingComment" : "Supplementary report by Dr F Maclean:
The specimen jar has been examined and no residual tissue is apprarent.  Multiple deeper levels of the blocks have been examined and an additional small benign lymph node measuring less than 1mm in maximum dimension has been identified. There is no additional evidence of malignancy. The above synpotic has been amended to reflect the resence of this node."
  }
}